Lunai Bioworks Inc.: 10-K filed 2020-09-23
What Lunai Bioworks Inc. reported in its annual report filed 2020-09-23 (fiscal FY 2020): 36 published measures, 71 facts as tagged in accession 0001731122-20-000975.
This filing
- Form
- 10-K (annual report)
- Filed
- 2020-09-23
- Fiscal period
- fiscal FY 2020
- Accession
- 0001731122-20-000975 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lunai Bioworks Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 178,102,059 | USD | |
| At 2019-06-30 | 179,877,353 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 11,829,798 | USD | |
| At 2019-06-30 | 6,777,416 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 166,272,261 | USD | |
| At 2019-06-30 | 173,099,937 | USD | |
| At 2018-06-30 | 158,737,734 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 8,696,361 | USD | |
| At 2019-06-30 | 12,282,224 | USD | |
| At 2018-06-30 | 15,600,865 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -11,416,358 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -18,016,480 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -10,459,422 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -8,507,341 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 184,463 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 716,669 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 7,200,000 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 6,020,000 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -184,463 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -716,669 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -64,188,198 | USD | |
| At 2019-06-30 | -52,771,840 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 778,118 | USD | |
| At 2019-06-30 | 687,517 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 884,724 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 2,124,967 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -11,923,768 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -10,990,032 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 8,941,209 | USD | |
| At 2019-06-30 | 12,494,987 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 104,280 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 43 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,334,798 | USD | |
| At 2019-06-30 | 1,110,416 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 11,640,000 | USD | |
| At 2019-06-30 | 11,640,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 77,323 | USD | |
| At 2019-06-30 | 93,299 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 11,923,768 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 10,990,032 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 4,694,349 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 2,498,107 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 46,497,409 | shares | |
| At 2019-06-30 | 45,273,924 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 230,497,225 | USD | |
| At 2019-06-30 | 225,765,432 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -41,416 | USD | |
| At 2019-06-30 | 101,818 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,703,859 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,803,064 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 931,131 | USD | |
| At 2019-06-30 | 746,669 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 153,013 | USD | |
| At 2019-06-30 | 59,152 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 470,636 | USD | |
| At 2019-06-30 | 336,853 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | -11,599,592 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -18,120,342 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 7,120,835 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 8,420,216 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 93,861 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 56,555 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 108,584 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 71,709 | USD | 365 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 14,722 | USD | 366 |
| 2018-07-01 to 2019-06-30 | 15,154 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 507,410 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -7,026,448 | USD | 365 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2019-06-30 | 43 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2020-06-30 | 59,314 | USD | 366 |
| 2018-07-01 to 2019-06-30 | -29,946 | USD | 365 |
Inspect the source
- Entity
- Lunai Bioworks Inc. / CIK 0001527728
- Captured
- 2026-09-19T11:18:43.497Z
- SEC response SHA-256
ac98dc0ce9d3f6a81ccca9ca1f946e5772f94eabe3529dac2d726fef17abed57
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001527728.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))